Ticker Scorecard - CARM Basics Company: Carisma Therapeutics, Inc. IPO Date: February 3, 2014 Sector: Healthcare Industry: Biotech Market Cap: $18.8M Activated in VL: True Average Daily Range Avg Daily Range: $0.14 | 4.34% Avg Daily Range (30 D): $0.02 | 4.69% Avg Daily Range (90 D): $0.03 | 4.30% Institutional Daily Volume Avg Daily Volume: .24M Avg Daily Volume (30 D): .3M Avg Daily Volume (90 D): .24M Trade Size Avg Trade Size (Sh.): 142 Avg Trade Size (Sh.) (30 D): 376 Avg Trade Size (Sh.) (90 D): 350 Institutional Trades Total Inst.Trades: 12 Avg Inst. Trade: $3.47M Avg Inst. Trade (30 D): $3.25M Avg Inst. Trade (90 D): $3.25M Avg Inst. Trade Volume: .57M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.58M Avg Closing Trade (30 D): $3.25M Avg Closing Trade (90 D): $3.25M Avg Closing Volume: 784.55K     News Jun 26, 2024 @ 6:01 PM In-Depth Examination Of 5 Analyst Recommendations ... Source: Benzinga Insights May 17, 2024 @ 3:01 PM The Analyst Verdict: CARISMA Therapeutics In The E... Source: Benzinga Insights May 9, 2024 @ 12:35 PM Carisma Therapeutics Inc. (CARM) Reports Q1 Loss, ... Source: Zacks Equity Research May 2, 2024 @ 2:01 PM Carisma Therapeutics Inc. (CARM) May Report Negati... Source: Zacks Equity Research Apr 4, 2024 @ 1:55 PM Here's Why CARISMA THERAP (CARM) Is a Great 'Buy t... Source: Zacks Equity Research Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.31 $-.27 $-.46 Diluted EPS $-.31 $-.27 $-.46 Revenue $ 3.4M $ 9.2M $ 3.4M Gross Profit $ $ $ Net Income / Loss $ -12.7M $ -11.16M $ -18.98M Operating Income / Loss $ -13.14M $ -11.67M $ -19.51M Cost of Revenue $ $ $ Net Cash Flow $ -13.48M $ -16.15M $ -21.09M PE Ratio     Splits Mar 08, 2023:   1:2